(PDF) Inhibition of Platelet-Rich Arterial Thrombus in

Inhibition of Platelet-Rich Arterial Thrombus in Vivo: Acute Antithrombotic Effect of Intravenous HMG-CoA Reductase Therapy

Arteriosclerosis, Thrombosis, and Vascular Biology - United States

doi 10.1161/atvbaha.109.190884

Full Text

Abstract

Available in full text

Categories

Cardiovascular Medicine

Date

September 1, 2009

Authors

Waldemar Wysokinski

Krzystof Karnicki

Robert D. McBane

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine

English

Rho-GTPase-Dependent Platelet-Neutrophil Interaction Affected by HMG-CoA Reductase Inhibition With Altered Adenosine Nucleotide Release and Function

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English

Features of the HMG 1 Subfamily of Genes Encoding HMG-CoA Reductase in Potato

Plant Molecular Biology

English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society

English

HMG CoA Reductase Inhibitors (Statins) for Dialysis Patients

English

Role of Gas6 Receptors in Platelet Signaling During Thrombus Stabilization and Implications for Antithrombotic Therapy

Journal of Clinical Investigation

English

Influence of HMG-CoA Reductase Inhibitor to Virological Response of Peginterferon/Ribavirin Combination Therapy in Chronic Hepatitis C

Acta Hepatologica Japonica

English

The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English

HMG-CoA Reductase Inhibitors, Other Lipid-Lowering Medication, Antiplatelet Therapy, and the Risk of Venous Thrombosis

Journal of Thrombosis and Haemostasis

English